Kodiak Sciences (KOD) incurred a loss of 84 cents per share in the third quarter of 2024, narrower than the Zacks Consensus Estimate of a loss of 90 cents. The company had incurred a loss of 95 cents per share in the year-ago quarter.The company currently does not have any approved products in its portfolio. As a result, it has yet to generate revenues.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.KOD’s Q3 Results in DetailResearch and development expenses were $31.9 million in the ...